Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report

doi:10.12998/wjcc.v8.i19.4527

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6746)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

406

WORD

252

HTML

4006

Figures (1-4)

259

Sum=4923

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

609

Download

1214

Sum=1823

Oct 6, 2020 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 6, 2020; 8(19): 4527-4534
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4527

Full Size Figure Download Figure

Figure 4 The mechanism of action of Janus kinases. JAK: Janus kinase; IL: Interleukin.

Citation: Li B, Li GW, Xue L, Chen YY. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(19): 4527-4534
URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4527.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4527